Cited by 25Metabolism and Genetic DisordersAmino Acid Enzymes and MetabolismGenomics and Rare Diseases

Expanding the genetic and phenotypic spectrum of branched‐chain amino acid transferase 2 deficiency

Open access
Knerr, Ina, Colombo, Roberto, Urquhart, Jill, Morais, Ana, Merinero, Begona, Oyarzabal, Alfonso, Pérez, Belén, Jones, Simon A. +13 more·2019·Journal of Inherited Metabolic Disease

Abstract

The first step in branched‐chain amino acid (BCAA) catabolism is catalyzed by the two BCAA transferase isoenzymes, cytoplasmic branched‐chain amino acid transferase (BCAT) 1, and mitochondrial BCAT2. Defects in the second step of BCAA catabolism cause maple syrup urine disease (MSUD), a condition which has been far more extensively investigated. Here, we studied the consequences of BCAT2 deficiency, an ultra‐rare condition in humans. We present genetic, clinical, and functional data in five individuals from four different families with homozygous or compound heterozygous BCAT2 mutations which were all detected following abnormal biochemical profile results or familial mutation segregation studies. We demonstrate that BCAT2 deficiency has a recognizable biochemical profile with raised plasma BCAAs and, in contrast with MSUD, low‐normal branched‐chain keto acids (BCKAs) with undetectable l‐allo‐isoleucine. Interestingly, unlike in MSUD, none of the individuals with BCAT2 deficiency developed acute encephalopathy even with exceptionally high BCAA levels. We observed wide‐ranging clinical phenotypes in individuals with BCAT2 deficiency. While one adult was apparently asymptomatic, three individuals had presented with developmental delay and autistic features. We show that the biochemical characteristics of BCAT2 deficiency may be amenable to protein‐restricted diet and that early treatment may improve outcome in affected individuals. BCAT2 deficiency is an inborn error of BCAA catabolism. At present, it is unclear whether developmental delay and autism are parts of the variable phenotypic spectrum of this condition or coincidental. Further studies will be required to explore this.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jimd.12135

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Additional BCAT2 mutations have been identified, ranging between homozygous or compound heterozygous BCAT2 mutations.

    “A more recent study identified several additional BCAT2 mutations that ranged between homozygous or compound heterozygous BCAT2 mutations (Knerr et al. 2019).”

    From Alzheimer’s disease: Targeting the glutamatergic system (2020) · cites this paper as Knerr et al. 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Karczewski KJ, Francioli LC, Tiao G, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss- of-function intolerance across human protein-coding genes. Bio- rxiv. 2019; https://www.biorxiv.org/content/10.1101/531210v2. · DOI

Cited by

Sorted by citations

Authors
Knerr, I., Colombo, R., Urquhart, J., Morais, A., Merinero, B., Oyarzabal, A., Pérez, B., Jones, S. A., Perveen, R., Preece, M. A., Rogers, Y., Treacy, E. P., Mayne, P., Zampino, G., MacKinnon, S., Wassmer, E., Yue, W. W., Robinson, I., Rodríguez‐Pombo, P., Olpin, S. E., & Banka, S.
Affiliations
  • Temple Street Children's University Hospital (IE)
  • Università Cattolica del Sacro Cuore (IT)
  • St Mary's Hospital (GB)
  • Centre for Biomedical Network Research on Rare Diseases (ES)
  • Centro de Diagnostico de Enfermedades Moleculares, Departamento de Biologia Molecular, Centro de Biologia Molecular Severo Ochoa, Centro de Investigacion Biomedica en Red de Enfermedades Raras Universidad Autonoma de Madrid Spain
  • University of Manchester (GB)
  • Birmingham Women’s and Children’s NHS Foundation Trust (GB)
  • Mater Misericordiae University Hospital (IE)
  • University of Oxford (GB)
  • Sheffield Children's NHS Foundation Trust (GB)
Corresponding author
Knerr, Ina
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2019-08
Volume
42
Issue
5
Pages
809-817
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W2948459858
Cited by
25
References
23
Citations by year
2026: 3 · 2025: 5 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 5 · 2019: 1
FWCI
2.07
Type
journal article
Language
en
Open access
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • European Regional Development Fund (PI12/02078)
  • Ministerio de Economía y Competitividad
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
BCAT2, branched-chain amino acid catabolism, maple syrup urine disease, inborn errors of metabolism, branched-chain keto acids, developmental delay, autism spectrum disorder, phenotypic variability, low-protein diet, compound heterozygosity, homozygous mutation
MeSH terms
Adolescent, Adult, Amino Acid Metabolism, Inborn Errors, Amino Acids, Branched-Chain, Transaminases, Brain, Child, Child, Preschool, Female, Homozygote, Humans, Magnetic Resonance Imaging, Male, Mitochondria, Mutation, Phenotype, Pregnancy Proteins, Minor Histocompatibility Antigens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review